One step forward promoting Pneumoslide and Pneumobact in India

The best tools for the serological diagnosis of atypical pneumonia now in the prestigious magazine Modern Medicare

After the successful scientific event “Pneumonia – Trends in Diagnosis” held last April 3rd, Transasia Bio-Medicals Ltd., new commercial partner of Vircell in India, starts a marketing campaign in the science magazine Modern Medicare.

This Promotional campaign highlights the benefits of Pneumoslide^® and Pneumobact^® as the most complete tools for the serological diagnosis of pneumonia. Pneumoslide^® allows the simultaneous detection of viruses and bacteria frequently associated to the infectious diseases in a single slide. Pneumobact^® focuses on the bacterial agents causing this disease. Nowadays, pneumonia remains one of the main causes of infant mortality in India.

Modern Medicare is the leading magazine in the healthcare and medical equipment sector. This monthly publication offers the latest tendencies within the sector, as well as analysis and opinion pieces about the healthcare industry. Furthermore, Modern Medicare has become the book of reference for the supplying of hospitals, specialist clinics and laboratories, amongst others. 

We hope that this promotional campaign achieves its objective and helps promote our products for the diagnosis of pneumonia. Vircell’s multitests will certainly allow a better evaluation of the patients and the application of more efficient treatments.